🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

15+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 15 of 15 recruiting trials for “Primary pulmonary tuberculosis

NARecruitingNCT07484490

Effects of the Active Cycle of Breathing Technique With and Without Balloon Blowing Therapy in Tuberculosis

👨‍⚕️ Nayab shahid, MS-PT, RIPHAH INTERNATINAAL UNIVERSITY📍 1 site📅 Started Jan 2026View details ↗
Phase 3RecruitingNCT07209761

A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis

👨‍⚕️ Simbarashe G Takuva, MD, MSc., Study Sponsor📍 33 sites📅 Started Oct 2025View details ↗
Phase 2RecruitingNCT07170800

A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets

🏥 WestVac Biopharma Co., Ltd.📍 7 sites📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT06192160

Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis

👨‍⚕️ Radojka Savic, PharmD, PhD, University of California📍 28 sites📅 Started Mar 2025View details ↗
Phase 2RecruitingNCT06748937

A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With Ethionamide

👨‍⚕️ Gifty Okyere-Manu, MBChB, TASK📍 1 site📅 Started Mar 2025View details ↗
Phase 4RecruitingNCT06476210

The Safety and Efficacy of BDL(Bedaquiline Plus Delamanid Plus Linezolid) Regimen in Subjects With Pulmonary Infection of Multi-drug Resistant Tuberculosis (MDR-TB) or Rifampicin-Resistant Tuberculosis (RR-TB)

👨‍⚕️ Yuhong Liu, Ph.D, Beijing Chest Hostal📍 7 sites📅 Started Jun 2024View details ↗
Phase 2RecruitingNCT06114628

Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB

🏥 University College, London📍 11 sites📅 Started Jan 2024View details ↗
Phase 2RecruitingNCT06199921

ATORvastatin in Pulmonary TUBerculosis

👨‍⚕️ Olanisun O Adewole, MD, Obafemi Awolowo University /Teaching Hospital, Ile- Ife, Osun State, Nigeria📍 8 sites📅 Started Jan 2024View details ↗
Phase 3RecruitingNCT06727864

Short Course Regimen in Low Risk Active Tuberculosis- a Multicenter, Randomized, Active-controlled, Trial

👨‍⚕️ Susan Shin-Jung Lee, MD, PhD, Kaohsiung Veterans General Hospital.📍 8 sites📅 Started Jan 2024View details ↗
NARecruitingNCT06127641

Rehabilitation of People With Post-tuberculosis Lung Disease

🏥 Centro Universitário Augusto Motta📍 2 sites📅 Started Oct 2023View details ↗
Phase 4RecruitingNCT06403943

Efficacy Safety BaiDiZiYin ShenQiYiFei Adjunctive Treatments Pulmonary Tuberculosis

👨‍⚕️ WENJUAN NIE, DR, Beijing Chest Hospital📍 1 site📅 Started May 2023View details ↗
Phase 2RecruitingNCT05807399

PanACEA - STEP2C -01

👨‍⚕️ Michael Hoelscher, Prof Dr., LMU University Hospital📍 10 sites📅 Started Apr 2023View details ↗
RecruitingNCT06706596

A Systemic Screening for TB Disease in High-risk Groups in Barcelona

👨‍⚕️ Cristina Vilaplana, MD, PhD, Fundació i Hospital Germans Trias i Pujol (IGTP-HUGTIP)📍 1 site📅 Started Jul 2022View details ↗
RecruitingNCT05756582

Prevalence of Latent Tuberculosis Infection in Health-care Workers and Students

👨‍⚕️ Angela Rizzi, MD, PhD, Catholic University of Sacred Heart📍 1 site📅 Started Nov 2021View details ↗
Phase 3RecruitingNCT04260477

Novel Triple-dose Tuberculosis Retreatment Regimen

👨‍⚕️ Sani Kadri, Ministry of Health, Niger📍 1 site📅 Started Mar 2021View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →